description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TTGGACAGGTCAGCAGACAGCCCATCCTTCAGGAAATCACAAATGTCCCGAGCCCGGAGCTTCCCAGACAACAGAAAGGAATGCTCAGATCGGGAGACCCAGCTCTATGATAAAGGTGTCAAAGGTGGAACCTATCCCAGGCGCTACCATGTGTCTGTGCATCACAAAGACTACAATGATGGCAGAAGAACATTTCCCCGAATACGACGGCATCAAGGCAACCTATTCACTCTGGTGCCCTCAAGTCGCTCCTTGAGCACAAATGGCGAGAACATGGGTGTAGCTGTGCAATACCTGGACCCCCGTGGGCGCCTACGGAGTGCAGACAGTGAGAATGCCCTCACTGTGCAGGAAAGGAATGTGCCAACCAAATCTCCTAGTGCTCCCATCAATTGGCGTCGGGGGAAGCTCCTGGGTCAAGGTGCCTTCGGCAGGGTCTACTTGTGCTATGATGTGGACACAGGACGTGAACTTGCTTCTAAGCAGGTCCAGTTTGACCCAGATAGTCCTGAGACAAGCAAGGAGGTGAGTGCTCTGGA
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... MAP3K3(26406), Map3k3(26406)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Ganesh Umapathy et al.
Science signaling, 7(349), ra102-ra102 (2014-10-30)
Anaplastic lymphoma kinase (ALK) is an important molecular target in neuroblastoma. Although tyrosine kinase inhibitors abrogating ALK activity are currently in clinical use for the treatment of ALK-positive (ALK(+)) disease, monotherapy with ALK tyrosine kinase inhibitors may not be an
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU089001-50UG | 04061828867165 |
| EMU089001-20UG | 04061828527588 |